Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127145111 | 12714511 | 1 | I | 2014 | 20160503 | 20160905 | 20160905 | PER | US-JAZZ-2016-US-008383 | JAZZ | 0.00 | F | Y | 0.00000 | 20160905 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127145111 | 12714511 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 127145111 | 12714511 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 127145111 | 12714511 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 127145111 | 12714511 | 4 | SS | NUVIGIL | ARMODAFINIL | 1 | 0 | ||||||||||||
| 127145111 | 12714511 | 5 | C | METROLOTION | METRONIDAZOLE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 6 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 7 | C | QUININE SULFATE. | QUININE SULFATE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 8 | C | FLECTOR | DICLOFENAC EPOLAMINE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 9 | C | Cod liver oil | COD LIVER OIL | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 10 | C | Doxycycline Hyclate dr | DOXYCYCLINE HYCLATE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 11 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 12 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 13 | C | LYRICA | PREGABALIN | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 14 | C | MOBIC | MELOXICAM | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 15 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 16 | C | VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | U | 0 | |||||||||||
| 127145111 | 12714511 | 17 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127145111 | 12714511 | 1 | Narcolepsy |
| 127145111 | 12714511 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127145111 | 12714511 | Acne | |
| 127145111 | 12714511 | Bronchitis | |
| 127145111 | 12714511 | Hypertension | |
| 127145111 | 12714511 | Neuralgia | |
| 127145111 | 12714511 | Pain in jaw | |
| 127145111 | 12714511 | Seasonal allergy | |
| 127145111 | 12714511 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127145111 | 12714511 | 1 | 200602 | 200602 | 0 | |
| 127145111 | 12714511 | 2 | 200602 | 200603 | 0 | |
| 127145111 | 12714511 | 3 | 200603 | 0 |